US Patent 8986972 Nucleic acid encoding DLL3 antibodies
Patent 8986972 was granted and assigned to Stem CentRx, Inc. on March, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
August 22, 2014
Date of Patent
March 24, 2015
Patent Applicant
Patent Application Number
14466939
Patent Inventor Names
David Liu
0
Orit Foord
0
Robert A. Stull
0
Scott J. Dylla
0
Hui Shao
0
Laura Saunders
0
Michael Torgov
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8986972 Nucleic acid encoding DLL3 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
